SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/F37A3E7B97CF0A00D70C0BF8971C64E83F434E8C46387A25C9A1B0980C83722ED3F6B673DEF5DEDCECA6C85F0D67F630>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/F37A3E7B97CF0A00D70C0BF8971C64E83F434E8C46387A25C9A1B0980C83722ED3F6B673DEF5DEDCECA6C85F0D67F630
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/F37A3E7B97CF0A00D70C0BF8971C64E83F434E8C46387A25C9A1B0980C83722ED3F6B673DEF5DEDCECA6C85F0D67F630
http://www.w3.org/2000/01/rdf-schema#comment
"ANP32E is an efficient prognostic marker and it promotes the G1/S transition and induces tumorigenesis of Triple-negative breast cancer cells by transcriptionally inducing E2F1."
xsd:string
http://purl.uniprot.org/uniprot/#_52B25A78CBB94C5A6E5D6894D0D28D7AD1C8F21C0C8DAEE9184B85E903B464D1E33A97C334E7E362BC088A959C28B5D9
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/F37A3E7B97CF0A00D70C0BF8971C64E83F434E8C46387A25C9A1B0980C83722ED3F6B673DEF5DEDCECA6C85F0D67F630
http://purl.uniprot.org/uniprot/Q9BTT0
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/F37A3E7B97CF0A00D70C0BF8971C64E83F434E8C46387A25C9A1B0980C83722ED3F6B673DEF5DEDCECA6C85F0D67F630
http://purl.uniprot.org/uniprot/#_Q9BTT0-mappedCitation-29633513
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/F37A3E7B97CF0A00D70C0BF8971C64E83F434E8C46387A25C9A1B0980C83722ED3F6B673DEF5DEDCECA6C85F0D67F630